Ascletis Pharma, Inc.'s market cap is currently HK$6.23B. The company's EPS TTM is HK$-0.271; its P/E ratio is ―; Ascletis Pharma, Inc. is scheduled to report earnings on March 24, 2025, and the estimated EPS forecast is HK$-0.16. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	¥ 56.60M	¥ 54.09M	¥ 76.88M	¥ 35.00M	¥ 173.44M
Gross Profit	¥ 25.99M	¥ -24.69M	¥ 39.17M	¥ -23.50M	¥ 124.28M
Operating Income	¥ -306.81M	¥ -262.82M	¥ -195.90M	¥ -156.43M	¥ -36.44M
EBITDA	¥ -126.09M	¥ -284.50M	¥ -169.35M	¥ -181.94M	¥ -73.64M
Net Income	¥ -144.72M	¥ -366.71M	¥ -202.14M	¥ -262.05M	¥ -155.50M
Balance Sheet
Cash & Short-Term Investments	¥ 2.30B	¥ 2.48B	¥ 2.50B	¥ 2.71B	¥ 2.99B
Total Assets	¥ 2.49B	¥ 2.66B	¥ 2.83B	¥ 3.07B	¥ 3.43B
Total Debt	¥ 8.42M	¥ 4.24M	¥ 2.75M	¥ 1.59M	¥ 3.81M
Net Debt	¥ -321.70M	¥ -2.47B	¥ -2.49B	¥ -2.71B	¥ -2.99B
Total Liabilities	¥ 148.94M	¥ 117.16M	¥ 100.89M	¥ 85.42M	¥ 102.17M
Stockholders' Equity	¥ 2.34B	¥ 2.54B	¥ 2.73B	¥ 2.98B	¥ 3.32B
Cash Flow
Free Cash Flow	¥ -163.32M	¥ -156.85M	¥ -154.13M	¥ -123.87M	¥ -102.57M
Operating Cash Flow	¥ -144.16M	¥ -142.45M	¥ -146.93M	¥ -84.91M	¥ -74.34M
Investing Cash Flow	¥ 149.84M	¥ -1.30B	¥ -274.49M	¥ 132.30M	¥ 602.27M
Financing Cash Flow	¥ -81.50M	¥ -1.42M	¥ -31.10M	¥ -21.67M	¥ -48.22M

Currency in CNY

Ascletis Pharma, Inc. Earnings and Revenue History

Income Statement >

Ascletis Pharma, Inc. Debt to Assets

Balance Sheet >

Ascletis Pharma, Inc. Cash Flow

Cash Flow >

Ascletis Pharma, Inc. Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing